The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share. The clinical-stage biotech company ...
News
- Fate Therapeutics: Q1 Earnings Snapshot
- US backs waiving intellectual property rules on vaccines
Dr. Michelle McMurry-Heath, chief executive of the Biotechnology Innovation Organization trade group, said in a statement that the decision will ...
- The Use of Artificial Intelligence in Healthcare Accelerated During the Pandemic. It's Here to Stay.
... solutions for population-health management, directly benefiting providers, health plans, employers and pharmaceutical and biotech organizations.
- Peptide and Heparin Market to Reflect Impressive Growth Rate Along with Top Leading Players ...
Cipla Ltd., VHB Life Sciences Limited, Troikaa Pharmaceuticals Ltd., Emcure Pharmaceuticals Pvt. Ltd., Samarth Life Sciences ... 1604 W San Antonio,.
- Xencor: Q1 Earnings Snapshot
The biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $34 million in the period, also topping ...